Mon, October 30, 2017

by: WOPRAI

Matthew Keating Maintained (CFR) at Hold with Increased Target to $106 on, Oct 30th, 2017

by: WOPRAI

Steven Alexopoulos Maintained (CFR) at Hold with Increased Target to $91 on, Oct 30th, 2017

by: WOPRAI

Michael Gambardella Maintained (CENX) at Hold with Decreased Target to $15 on, Oct 30th, 2017

by: WOPRAI

Michael Gambardella Downgraded (CENX) to Hold on, Oct 30th, 2017

by: WOPRAI

Atif Malik Maintained (TER) at Strong Buy with Increased Target to $48 on, Oct 30th, 2017

by: WOPRAI

Rich Kwas Maintained (TEN) at Hold with Decreased Target to $64 on, Oct 30th, 2017

by: WOPRAI

Grant Hofer Downgraded (BTE) to Sell on, Oct 30th, 2017

by: WOPRAI

Richard Carlson Maintained (BWA) at Buy with Increased Target to $65 on, Oct 30th, 2017

by: WOPRAI

Itay Michaeli Maintained (BWA) at Hold with Increased Target to $54 on, Oct 30th, 2017

by: WOPRAI

Rick Paterson Maintained (UNP) at Hold with Increased Target to $120 on, Oct 30th, 2017

by: WOPRAI

Joseph Vafi Maintained (WNS) at Strong Buy with Increased Target to $44 on, Oct 30th, 2017

by: WOPRAI

Puneet Jain Maintained (WNS) at Buy with Increased Target to $45 on, Oct 30th, 2017

by: WOPRAI

Mark Schappel Downgraded (SPSC) to Strong Sell on, Oct 30th, 2017

by: WOPRAI

Akshay Jagdale Maintained (THS) at Strong Buy with Decreased Target to $90 on, Oct 30th, 2017

by: WOPRAI

Brian Tanquilut Maintained (THC) at Strong Buy with Decreased Target to $20 on, Oct 30th, 2017

by: WOPRAI

Michael Rehaut Maintained (SWK) at Buy with Increased Target to $180 on, Oct 30th, 2017

by: WOPRAI

Dewey Steadman Maintained (SVRA) at Strong Buy with Increased Target to $25 on, Oct 30th, 2017

by: WOPRAI

Robert Ohmes Downgraded (UAA) to Sell on, Oct 30th, 2017

by: WOPRAI

Akshay Jagdale Maintained (TSN) at Strong Buy with Increased Target to $85 on, Oct 30th, 2017

by: WOPRAI

Kenneth Wong Maintained (BLKB) at Strong Buy with Increased Target to $112 on, Oct 30th, 2017

by: WOPRAI

Matthew Luchini Maintained (BLUE) at Buy with Increased Target to $162 on, Oct 30th, 2017

by: WOPRAI

William Katz Maintained (TROW) at Hold with Increased Target to $95 on, Oct 30th, 2017

by: WOPRAI

Manav Patnaik Maintained (TRU) at Buy with Increased Target to $55 on, Oct 30th, 2017

by: WOPRAI

Shlomo Rosenbaum Maintained (TRU) at Strong Buy with Increased Target to $59 on, Oct 30th, 2017

by: WOPRAI

Andrew Steinerman Maintained (TRU) at Buy with Increased Target to $60 on, Oct 30th, 2017

by: WOPRAI

Toni Kaplan Downgraded (TRU) to Hold on, Oct 30th, 2017

by: WOPRAI

Stanley Kovler Maintained (WDC) at Strong Buy with Increased Target to $115 on, Oct 30th, 2017

by: WOPRAI

Scott Gaffner Maintained (AVY) at Buy with Increased Target to $120 on, Oct 30th, 2017

by: WOPRAI

Daniel Bernstein Upgraded (VTR) to Buy on, Oct 30th, 2017

by: WOPRAI

Jeremy Campbell Maintained (VRTS) at Hold with Increased Target to $125 on, Oct 30th, 2017

by: WOPRAI

Faisel Khan Maintained (VNOM) at Strong Buy with Increased Target to $22 on, Oct 30th, 2017

by: WOPRAI

Derek Archila Maintained (VNDA) at Buy with Increased Target to $26 on, Oct 30th, 2017

by: WOPRAI

Alan Hellawell Downgraded (SOHU) to Hold on, Oct 30th, 2017

by: WOPRAI

Gregory Zhao Maintained (BIDU) at Hold with Decreased Target to $240 on, Oct 30th, 2017

by: WOPRAI

Alex Yao Maintained (BIDU) at Hold with Decreased Target to $225 on, Oct 30th, 2017

by: WOPRAI

Rahul Jasuja Initiated (ALNY) at Strong Buy and Held Target at $150 on, Oct 30th, 2017

by: WOPRAI

Ann Duignan Maintained (ALSN) at Hold with Increased Target to $41 on, Oct 30th, 2017

by: WOPRAI

Joseph Moore Downgraded (AMD) to Sell on, Oct 30th, 2017

by: WOPRAI

Douglas Harned Maintained (BA) at Buy with Increased Target to $310 on, Oct 30th, 2017

by: WOPRAI

Geoffrey Porges Maintained (ABBV) at Buy with Decreased Target to $107 on, Oct 30th, 2017

by: WOPRAI

Andrew Kaplowitz Maintained (ACM) at Strong Buy with Increased Target to $45 on, Oct 30th, 2017

by: WOPRAI

Ann Hynes Downgraded (ACHC) to Hold on, Oct 30th, 2017

by: WOPRAI

Brian Meredith Maintained (ACGL) at Strong Buy with Increased Target to $38 on, Oct 30th, 2017

by: WOPRAI

Itay Michaeli Maintained (VC) at Hold with Increased Target to $126 on, Oct 30th, 2017

by: WOPRAI

Jerry Liu Initiated (VIPS) at Hold and Held Target at $9 on, Oct 30th, 2017

by: WOPRAI

Ramsey El-Assal Maintained (V) at Strong Buy with Increased Target to $127 on, Oct 30th, 2017

by: WOPRAI

Simon Yarmak Upgraded (CAG) to Strong Buy on, Oct 30th, 2017

by: WOPRAI

Todd Bault Maintained (CB) at Hold with Increased Target to $173 on, Oct 30th, 2017

Derek Archila Maintained (VNDA) at Buy with Increased Target to $26 on, Oct 30th, 2017

Derek Archila of Oppenheimer, Maintained "Vanda Pharmaceuticals Inc." (VNDA) at Buy with Increased Target from $21 to $26 on, Oct 30th, 2017.

Derek, nor any peers, have made any analyst calls on VNDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30


Similar Stocks and Investing Publications